Compare Fiserv Inc. Common Stock (FISV) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiserv Inc. Common Stock vs TransMedics Group Inc — how do they compare? Fiserv Inc. Common Stock trades at $46.1 (market cap $24.50B), while TransMedics Group Inc trades at $75.3 (market cap $2.62B). The key difference: Fiserv Inc. Common Stock is far larger — about 9.4× TransMedics Group Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and TransMedics Group Inc for 24 Days on average.
| FISV | TMDX | |
|---|---|---|
Market Cap | $24.50B | $2.62B |
Volume | 3,682,634 | 891,435 |
Sector | Technology | Health |
52-Week High | $126.54 | $150.42 |
52-Week Low | $44.36 | $61.99 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $52.29B | $3.01B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiserv Inc. Common Stock
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
